{"id":"https://openalex.org/W3141101440","doi":"https://doi.org/10.1111/apt.12966","title":"Editorial: adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease","display_name":"Editorial: adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease","publication_year":2014,"publication_date":"2014-10-10","ids":{"openalex":"https://openalex.org/W3141101440","doi":"https://doi.org/10.1111/apt.12966","mag":"3141101440","pmid":"https://pubmed.ncbi.nlm.nih.gov/25303382"},"language":"en","primary_location":{"id":"doi:10.1111/apt.12966","doi":"https://doi.org/10.1111/apt.12966","is_oa":true,"landing_page_url":"https://doi.org/10.1111/apt.12966","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.12966","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.12966","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062491410","display_name":"Alan C. Moss","orcid":"https://orcid.org/0000-0003-0179-5477","observed_orcids":["https://orcid.org/0000-0003-0179-5477","https://orcid.org/0009-0007-0879-3884"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A. C. Moss","raw_affiliation_strings":["Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062491410"],"corresponding_institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"10","first_page":"1249","last_page":"1249"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.9819999933242798},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.9390000104904175},{"id":"https://openalex.org/keywords/loss-of-response","display_name":"loss of response","score":0.7979999780654907},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.9120000004768372},{"id":"https://openalex.org/keywords/once-weekly-dosing","display_name":"weekly dosing","score":0.722000002861023},{"id":"https://openalex.org/keywords/glucocorticoid-therapy","display_name":"glucocorticoid therapy","score":0.628000020980835},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.6420000195503235},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.6970000267028809},{"id":"https://openalex.org/keywords/drug-concentration","display_name":"drug concentration","score":0.5210000276565552},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.5730000138282776},{"id":"https://openalex.org/keywords/vedolizumab","display_name":"vedolizumab","score":0.8009999990463257},{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":0.9319999814033508},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/placebo-effect","display_name":"placebo effect","score":0.4699999988079071},{"id":"https://openalex.org/keywords/endoscopic-inflammation","display_name":"endoscopic inflammation","score":0.7350000143051147},{"id":"https://openalex.org/keywords/confounding-factors","display_name":"confounding factors","score":0.44600000977516174},{"id":"https://openalex.org/keywords/patient-expectations","display_name":"patient expectations","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.9745602011680603},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.928205132484436},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7189294099807739},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.690979540348053},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5207086205482483},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5083548426628113},{"id":"https://openalex.org/C184138380","wikidata":"https://www.wikidata.org/wiki/Q948919","display_name":"Paradoxical reaction","level":3,"score":0.4793458878993988},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.467602401971817},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.46482306718826294},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.44946885108947754},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.1129482090473175},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/apt.12966","doi":"https://doi.org/10.1111/apt.12966","is_oa":true,"landing_page_url":"https://doi.org/10.1111/apt.12966","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.12966","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:25303382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25303382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary pharmacology & therapeutics","raw_type":"Editorial"}],"best_oa_location":{"id":"doi:10.1111/apt.12966","doi":"https://doi.org/10.1111/apt.12966","is_oa":true,"landing_page_url":"https://doi.org/10.1111/apt.12966","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.12966","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308605","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3141101440.pdf","grobid_xml":"https://content.openalex.org/works/W3141101440.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W1968331553","https://openalex.org/W2011837830","https://openalex.org/W2033582886","https://openalex.org/W2036144913","https://openalex.org/W2069921868","https://openalex.org/W2084549982","https://openalex.org/W2095161324","https://openalex.org/W2104160273","https://openalex.org/W2123352987"],"related_works":["https://openalex.org/W2036144913","https://openalex.org/W2555199940","https://openalex.org/W2804093863","https://openalex.org/W2060718385","https://openalex.org/W2914537607","https://openalex.org/W1999488981","https://openalex.org/W4248286693","https://openalex.org/W2030638161","https://openalex.org/W2127845405","https://openalex.org/W2097741655"],"abstract_inverted_index":{"Loss":[0],"of":[1,13,36,65,69,107,116,122,133,181,187,194,247,268,303,313,341,357,362],"response":[2,44,81,91,126,146],"to":[3,22,29,39,82,92,98,110,147,174,205,237,240,316],"anti-TNF":[4,38],"agents":[5,326],"is":[6,217,277],"a":[7,11,213,258],"common":[8],"problem,":[9],"for":[10,113,261,281,297,329,378],"variety":[12],"reasons":[14],"that":[15,104,177],"have":[16],"been":[17,28],"reviewed":[18],"elsewhere.1":[19],"The":[20,51],"reaction":[21],"this":[23,169,245,348],"problem":[24],"in":[25,71,86,168,221,288,320,347],"practise":[26],"has":[27,367],"empirically":[30],"increase":[31],"the":[32,37,62,79,158,179,182,185,202,255,301,321,339,365],"dose":[33,67,149,206,282,311,342],"or":[34,211,344],"frequency":[35],"try":[40],"and":[41,45,191,231,253,274,337,354,375,385],"re-capture":[42],"clinical":[43,80,251],"remission,":[46],"with":[47,73,143,223,257],"mixed":[48],"short-term":[49],"results.2":[50],"recent":[52],"study":[53,248],"by":[54],"Ma":[55],"et":[56],"al.":[57],"provides":[58,254],"additional":[59],"data":[60],"on":[61,285,307],"long-term":[63],"results":[64],"empiric":[66,295,310],"escalation":[68,207,283,296,312,343],"adalimumab":[70,84,148,188,314],"patients":[72,87,108,124,222,289],"Crohn's":[74,224],"disease.3":[75],"They":[76],"retrospectively":[77],"measured":[78,165],"weekly":[83,111],"dosing":[85,305],"who":[88,290],"had":[89],"lost":[90,125],"every":[93],"other":[94,99],"week":[95],"dosing.":[96],"Similar":[97],"observational":[100],"studies,":[101],"they":[102],"noted":[103],"about":[105],"80%":[106],"responded":[109],"dosing,":[112],"an":[114,131,144,219],"average":[115,132],"69":[117],"weeks.":[118,135],"Unfortunately,":[119],"over":[120,128],"half":[121],"these":[123],"again":[127],"time,":[129],"within":[130],"50":[134],"Only":[136],"concurrent":[137],"glucocorticosteroid":[138],"use":[139],"was":[140,156],"significantly":[141],"associated":[142],"individual's":[145],"escalation,":[150],"making":[151,160],"one":[152],"wonder":[153],"if":[154,201],"it":[155],"actually":[157],"glucocorticosteroids":[159],"them":[161],"feel":[162],"better.":[163],"Retrospectively":[164],"outcomes,":[166],"like":[167],"study,":[170],"are":[171,229,235],"always":[172],"subject":[173],"confounding":[175],"factors":[176],"limit":[178],"robustness":[180],"conclusions.":[183],"In":[184,300],"absence":[186,302],"drug":[189,286,308],"levels,":[190,309],"objective":[192],"assessment":[193],"endoscopic":[195],"inflammation,":[196],"we":[197],"do":[198],"not":[199],"know":[200],"'clinical":[203],"response'":[204],"reflected":[208],"improved":[209],"pharmacokinetics,":[210],"just":[212],"placebo":[214],"effect.4":[215],"This":[216],"particularly":[218],"issue":[220],"disease,":[225],"where":[226],"overlap":[227],"complications":[228],"common,":[230],"physician-reported":[232],"symptom":[233],"scores":[234],"known":[236],"be":[238],"sensitive":[239],"non-inflammatory":[241],"symptoms.5,":[242],"6":[243],"However,":[244],"type":[246],"does":[249],"reflect":[250],"experience,":[252],"gastroenterologist":[256],"reference":[259],"point":[260],"their":[262],"patients'":[263,318],"expectations":[264],"using":[265],"similar":[266],"measures":[267],"success":[269],"('clinical":[270],"response').":[271],"A":[272],"scientific":[273],"economic":[275],"case":[276],"currently":[278],"being":[279],"made":[280],"based":[284,306],"levels":[287],"lose":[291],"response,":[292],"rather":[293],"than":[294],"all.7,":[298],"8":[299],"individualised":[304],"appears":[315],"improve":[317],"symptoms":[319],"medium":[322],"term.2":[323],"As":[324],"new":[325],"become":[327,351],"available":[328],"inflammatory":[330],"bowel":[331],"disease":[332],"(for":[333],"example":[334],"vedolizumab,":[335],"tofacitininb":[336],"ustekinumab),":[338],"choice":[340],"class":[345],"switch":[346],"setting":[349],"will":[350],"more":[352],"nuanced":[353],"personalised.9":[355],"Declaration":[356,361],"personal":[358],"interests:":[359,364],"None.":[360],"funding":[363],"author":[366],"received":[368],"grant":[369],"support":[370],"from":[371,381],"Pfizer":[372],"(to":[373],"BIDMC),":[374],"consulting":[376],"fees":[377],"advisory":[379],"boards":[380],"Janssen,":[382],"Abbott,":[383],"Roche":[384],"Bayer.":[386]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-04-13T00:00:00"}